Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SUPN > SEC Filings for SUPN > Form 8-K on 5-Sep-2013All Recent SEC Filings

Show all filings for SUPERNUS PHARMACEUTICALS INC

Form 8-K for SUPERNUS PHARMACEUTICALS INC


5-Sep-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events

On August 29, 2013, Supernus issued a press release announcing that the Company's management will be presenting an overview of the Company at investor conferences on September 9, 2013 and September 12, 2013. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

On September 5, 2013, Supernus issued a press release announcing that Trokendi XR is now available to patients in the United States. Trokendi XR is a novel once-daily extended release formulation of topiramate for the treatment of epilepsy. The product has been shipped to major wholesalers in the market, and the Company's sales force is promoting the product to physicians. A copy of this press release is furnished as Exhibit 99.2 hereto and is incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits

(d) Exhibits

The following documents are furnished as Exhibits pursuant to Item 8.01 hereof:

Exhibit 99.1 - Press Release dated August 29, 2013 of the Company announcing that the Company's management will be presenting at two investor conferences in September 2013.

Exhibit 99.2 - Press Release dated September 5, 2013 of the Company announcing the commercial launch of Trokendi XR in the United States.



  Add SUPN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SUPN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.